Contact Us
Cardiogenomics Global Market Report 2025
Global Cardiogenomics Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : September 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cardiogenomics Global Market Report 2025

By Product Type (Testing Kits, Reagents, Instruments, Software, Services); By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies); By Application (Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, OtherApplications); By End-User (Hospitals And Clinics, Diagnostic Laboratories, Research Institutes); Subsegments: By Testing Kits (PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits); By Reagents (Enzymes, Probes, Buffers); By Instruments (Sequencers, Genotyping instruments); By Software (Data analysis software, Reporting platforms); By Services (Genetic testing services, Counseling services, Data analysis services) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cardiogenomics Market Overview

• Cardiogenomics market size has reached to $1.50 billion in 2024

• Expected to grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%

• Growth Driver: Increasing Demand For Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches

• Market Trend: Advancements In Genomic Medicine For Early Detection And Personalized Treatment

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiogenomics Market?

Cardiogenomics refers to the scientific study of how variations in an individual’s genetic makeup influence the risk, onset, and progression of cardiovascular diseases. It plays a crucial role in enabling personalized prevention, accurate diagnosis, and targeted treatment strategies for improved heart health outcomes.

The main product types of cardiogenomics are testing kits, reagents, instruments, software, and services. Testing kits refers to packaged tools and consumables designed to perform specific genetic tests. The technologies employed comprise next-generation sequencing, polymerase chain reaction, microarrays, and others. These are applied in applications including congenital heart diseases, cardiomyopathies, arrhythmias, coronary artery disease, and others, and serving end-users including hospitals and clinics, diagnostic laboratories, research institutes, and others.

Cardiogenomics Market Size and growth rate 2025 to 2029: Graph

What Is The Cardiogenomics Market Size 2025 And Growth Rate?

The cardiogenomics market size has grown rapidly in recent years. It will grow from $1.50 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing application of polygenic risk scores in cardiac care, growing investments in genomic research and development, rising government and private funding for cardiovascular genomics, rising interest in preventive cardiology through genetic insights, and growing emphasis on population-scale genomic studies.

What Is The Cardiogenomics Market Growth Forecast?

The cardiogenomics market size is expected to see rapid growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing prevalence of cardiovascular diseases, rising adoption of genetic testing for early risk detection, increasing awareness of precision medicine approaches, and rising availability of direct-to-consumer genetic testing services. Major trends in the forecast period include technology innovations in sequencing enable precise cardiac analysis, integration of genomics with health records supports personalized care, developments in polygenic risk scoring improve early disease prediction, advancements in bioinformatics speed up genomic data interpretation, and technology platforms enable high-throughput genetic testing.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How the Cardiogenomics Market Segmented?

1) By Product Type: Testing Kits, Reagents, Instruments, Software, Services

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies

3) By Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, OtherApplications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users

Subsegments:

1) By Testing Kits: PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits

2) By Reagents: Enzymes, Probes, Buffers

3) By Instruments: Sequencers, Genotyping instruments, Microarray scanners

4) By Software: Data analysis software, Reporting platforms, Bioinformatics tools

5) By Services: Genetic testing services, Counseling services, Data analysis services

What Is Driving The Cardiogenomics Market? Increasing Demand For Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches

The increasing demand for personalized medicine is expected to propel the growth of the cardiogenomics market going forward. Personalized medicine refers to a healthcare approach that tailors prevention, diagnosis, and treatment to an individual’s genetic, environmental, and lifestyle factors. Increasing personalized medicine is driven by advances in genomics, allowing deeper understanding of individual genetic variations and enabling more precise, targeted treatments that improve patient outcomes and reduce trial-and-error in therapies. Cardiogenomics supports personalized medicine by using genetic insights to tailor cardiovascular disease prevention, diagnosis, and treatment to an individual’s unique genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing demand for personalized medicine is driving the growth of the cardiogenomics industry.

Who Are The Major Players In The Global Cardiogenomics Market?

Major companies operating in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic

What Are The Key Trends Of The Global Cardiogenomics Market? Advancements In Genomic Medicine For Early Detection And Personalized Treatment

Major companies operating in the cardiogenomics market are focusing on developing innovative solutions such as oncogenomics to enhance early detection and personalized treatment of cardiovascular-related cancers. Oncogenomics refers to the study of cancer-related genes and their mutations to understand cancer development and progression and to develop targeted therapies and personalized treatment approaches. For instance, in April 2025, Fortis Healthcare Ltd., an India-based healthcare company, launched a Fortis Institute of Genomic Medicine in India to advance genetic research and personalized medicine. It transforms patient care by enabling early disease detection, precise diagnosis, and personalized treatment across specialties such as oncology, cardiology, and neurology. It empowers targeted therapies, improves treatment outcomes, and supports preventive care for hereditary conditions. The institute’s purpose is to advance precision medicine through a multidisciplinary team and innovative technologies, making healthcare more personalized and effective for Indian patients.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Cardiogenomics Market? Letsgetchecked Acquires Veritas Genetics Inc. And Veritas Intercontinental S.L. To Expand Cardiogenomics Testing And Personalized Healthcare

In March 2025, Tempus AI Inc., a US-based technology company, acquired Ambry Genetics Corporation for an undisclosed amount. With this acquisition, Tempus AI Inc. aims to leverage genetic testing and AI-driven data to expand its precision medicine capabilities, improve patient outcomes, and provide comprehensive, personalized healthcare across multiple disease areas. Ambry Genetics Corporation is a US-based genetic testing and precision medicine company that offers cardiogenomics services.

What Is The Regional Outlook For The Global Cardiogenomics Market?

North America was the largest region in the cardiogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiogenomics Market?

The cardiogenomics market consists of revenues earned by entities by providing services such as genetic testing and screening, risk assessment and prediction, and counseling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics market also includes sales of cardiogenomic testing panels, genetic testing panels, and direct-to-consumer (DTC) genetic tests. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cardiogenomics Industry?

The cardiogenomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cardiogenomics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.74 billion
Revenue Forecast In 2034 $3.10 billion
Growth Rate CAGR of 15.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product Type, Technology, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cardiogenomics Market Characteristics

3. Cardiogenomics Market Trends And Strategies

4. Cardiogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiogenomics Growth Analysis And Strategic Analysis Framework

5.1. Global Cardiogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cardiogenomics Market Growth Rate Analysis

5.4. Global Cardiogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cardiogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cardiogenomics Total Addressable Market (TAM)

6. Cardiogenomics Market Segmentation

6.1. Global Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Testing Kits

Reagents

Instruments

Software

Services

6.2. Global Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Next-Generation Sequencing

Polymerase Chain Reaction

Microarray

Other Technologies

6.3. Global Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Congenital Heart Diseases

Cardiomyopathies

Arrhythmias

Coronary Artery Disease

OtherApplications

6.4. Global Cardiogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Laboratories

Research Institutes

Other End Users

6.5. Global Cardiogenomics Market, Sub-Segmentation Of Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pcr (Polymerase Chain Reaction) Kits

Microarray Kits

Ngs (Next Generation Sequencing) Kits

6.6. Global Cardiogenomics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Enzymes

Probes

Buffers

6.7. Global Cardiogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sequencers

Genotyping Instruments

Microarray Scanners

6.8. Global Cardiogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Analysis Software

Reporting Platforms

Bioinformatics Tools

6.9. Global Cardiogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Testing Services

Counseling Services

Data Analysis Services

7. Cardiogenomics Market Regional And Country Analysis

7.1. Global Cardiogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cardiogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiogenomics Market

8.1. Asia-Pacific Cardiogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiogenomics Market

9.1. China Cardiogenomics Market Overview

9.2. China Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiogenomics Market

10.1. India Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiogenomics Market

11.1. Japan Cardiogenomics Market Overview

11.2. Japan Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiogenomics Market

12.1. Australia Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiogenomics Market

13.1. Indonesia Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiogenomics Market

14.1. South Korea Cardiogenomics Market Overview

14.2. South Korea Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiogenomics Market

15.1. Western Europe Cardiogenomics Market Overview

15.2. Western Europe Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiogenomics Market

16.1. UK Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiogenomics Market

17.1. Germany Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiogenomics Market

18.1. France Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiogenomics Market

19.1. Italy Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiogenomics Market

20.1. Spain Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiogenomics Market

21.1. Eastern Europe Cardiogenomics Market Overview

21.2. Eastern Europe Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiogenomics Market

22.1. Russia Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiogenomics Market

23.1. North America Cardiogenomics Market Overview

23.2. North America Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiogenomics Market

24.1. USA Cardiogenomics Market Overview

24.2. USA Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiogenomics Market

25.1. Canada Cardiogenomics Market Overview

25.2. Canada Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiogenomics Market

26.1. South America Cardiogenomics Market Overview

26.2. South America Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiogenomics Market

27.1. Brazil Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiogenomics Market

28.1. Middle East Cardiogenomics Market Overview

28.2. Middle East Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiogenomics Market

29.1. Africa Cardiogenomics Market Overview

29.2. Africa Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiogenomics Market Competitive Landscape And Company Profiles

30.1. Cardiogenomics Market Competitive Landscape

30.2. Cardiogenomics Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Laboratory Corporation of America Holdings (Labcorp) Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Cardiogenomics Market Other Major And Innovative Companies

31.1. Myriad Genetics Inc.

31.2. ARUP Laboratories

31.3. BGI Genomics Co. Ltd.

31.4. Invitae Corporation

31.5. GeneDx Inc.

31.6. Helix OpCo LLC

31.7. SOPHiA GENETICS SA

31.8. Baylor Genetics

31.9. Blueprint Genetics

31.10. Novogenia GmbH

31.11. Veritas Genetics

31.12. Dante Genomics

31.13. Gene by Gene Ltd.

31.14. GENinCode Plc.

31.15. UAB Cardiogenomics Clinic

32. Global Cardiogenomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiogenomics Market

34. Recent Developments In The Cardiogenomics Market

35. Cardiogenomics Market High Potential Countries, Segments and Strategies

35.1 Cardiogenomics Market In 2029 - Countries Offering Most New Opportunities

35.2 Cardiogenomics Market In 2029 - Segments Offering Most New Opportunities

35.3 Cardiogenomics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cardiogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cardiogenomics Market, Sub-Segmentation Of Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cardiogenomics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cardiogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cardiogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cardiogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cardiogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cardiogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Thermo Fisher Scientific Inc. Financial Performance
  • Table 81: Laboratory Corporation of America Holdings (Labcorp) Financial Performance
  • Table 82: Quest Diagnostics Incorporated Financial Performance
  • Table 83: Illumina Inc. Financial Performance
  • Table 84: QIAGEN N.V. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cardiogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cardiogenomics Market, Sub-Segmentation Of Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cardiogenomics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cardiogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cardiogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cardiogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cardiogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cardiogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 81: Laboratory Corporation of America Holdings (Labcorp) Financial Performance
  • Figure 82: Quest Diagnostics Incorporated Financial Performance
  • Figure 83: Illumina Inc. Financial Performance
  • Figure 84: QIAGEN N.V. Financial Performance

Frequently Asked Questions

Cardiogenomics refers to the scientific study of how variations in an individual’s genetic makeup influence the risk, onset, and progression of cardiovascular diseases. It plays a crucial role in enabling personalized prevention, accurate diagnosis, and targeted treatment strategies for improved heart health outcomes. For further insights on this market, request a sample here

The market major growth driver - Increasing Demand For Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches. For further insights on this market, request a sample here

The cardiogenomics market size has grown rapidly in recent years. It will grow from $1.50 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing application of polygenic risk scores in cardiac care, growing investments in genomic research and development, rising government and private funding for cardiovascular genomics, rising interest in preventive cardiology through genetic insights, and growing emphasis on population-scale genomic studies. The cardiogenomics market size is expected to see rapid growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing prevalence of cardiovascular diseases, rising adoption of genetic testing for early risk detection, increasing awareness of precision medicine approaches, and rising availability of direct-to-consumer genetic testing services. Major trends in the forecast period include technology innovations in sequencing enable precise cardiac analysis, integration of genomics with health records supports personalized care, developments in polygenic risk scoring improve early disease prediction, advancements in bioinformatics speed up genomic data interpretation, and technology platforms enable high-throughput genetic testing. For further insights on this market, request a sample here

The cardiogenomics market covered in this report is segmented as
1) By Product Type: Testing Kits, Reagents, Instruments, Software, Services
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies
3) By Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, OtherApplications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users Subsegments:
1) By Testing Kits: PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits
2) By Reagents: Enzymes, Probes, Buffers
3) By Instruments: Sequencers, Genotyping instruments, Microarray scanners
4) By Software: Data analysis software, Reporting platforms, Bioinformatics tools
5) By Services: Genetic testing services, Counseling services, Data analysis services For further insights on this market,
request a sample here

North America was the largest region in the cardiogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic For further insights on this market, request a sample here.

Major trends in this market include Advancements In Genomic Medicine For Early Detection And Personalized Treatment For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top